Interactions Between Circulating Tumor Cells and the Immune System in Colorectal Cancer: Friends or Foes?
Cancers · 29.06.2026 · 18 (13) · 2104
DOI: 10.3390/cancers18132104 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 29.06.2026. Verfasst von Michela De Meo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Liquid Biopsy Unit, Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Colorectal cancer (CRC) is a leading cause of cancer death worldwide, mainly due to metastasis. Circulating tumor cells (CTCs) act as the biological “seeds” of dissemination, traveling through the bloodstream to colonize distant organs. However, the blood is a hostile environment where CTCs must constantly face immune pressure. This review explores the bidirectional interactions between CTCs and immune cells in CRC, asking whether CTCs are merely vulnerable targets of immunosurveillance or can exploit the immune system for survival and metastasis. We dissect intrinsic and extrinsic immune evasion mechanisms, including MHC-I modulation, immune checkpoint expression (PD-L1, CD47, FasL), platelet cloaking, and neutrophil extracellular traps (NETs). Furthermore, we examine how CTCs form heterotypic clusters with monocytes, neutrophils, and lymphocytes, creating pro-metastatic niches and promoting phenotypic plasticity. The impact of CTCs on systemic immunity, including reprogramming of NK cells, T lymphocytes, and myeloid-derived suppressor cells (MDSCs), is discussed. Importantly, we highlight the emerging role of CTCs as dynamic biomarkers for immunotherapy, focusing on the predictive value of PD-L1+ CTCs and the potential of CTC-derived neoantigens for personalized vaccination. Despite progress, challenges remain in standardization, detection sensitivity, and clinical validation. Understanding the equilibrium between immune elimination and evasion by CTCs is crucial to develop novel interventions that interrupt the metastatic dialog and improve outcomes for CRC patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Liquid Biopsy Unit, Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
- Department of Life Science, Health, and Health Professions, Link Campus University, 00165 Rome, Italy.
ORCID-Profile: Michela De Meo, Chiara Nicolazzo
Zitieren
APA
De Meo, M., & Nicolazzo, C. (2026). Interactions Between Circulating Tumor Cells and the Immune System in Colorectal Cancer: Friends or Foes?. Cancers, 18(13), 2104. https://doi.org/10.3390/cancers18132104
Vancouver
De Meo M, Nicolazzo C. Interactions Between Circulating Tumor Cells and the Immune System in Colorectal Cancer: Friends or Foes?. Cancers. 2026;18(13):2104. doi:10.3390/cancers18132104
BibTeX
@article{DeMeo2026,
author = {De Meo, Michela and Nicolazzo, Chiara},
title = {Interactions Between Circulating Tumor Cells and the Immune System in Colorectal Cancer: Friends or Foes?},
journal = {Cancers},
year = {2026},
volume = {18},
number = {13},
pages = {2104},
doi = {10.3390/cancers18132104}
}
EUVIMED